P108
P20
Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerNivolumab and Ipilimumab in Treating Patients With Rare TumorsCombination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairVaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in SurgeryErlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerIpilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced Melanoma1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) TherapyDasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerLenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaDasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland TumorsBrachytherapy in Treating Patients With Prostate CancerRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeRadiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck CancerRadiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerTestosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentFood Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate CancerGRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)Tivantinib in Treating Patients With Metastatic Prostate CancerS0820, Adenoma and Second Primary Prevention TrialARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung CancerA Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerMK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous TherapyPhase 3 Study of BGB-A317 Versus Sorafenib in Patients With Unresectable HCCAzacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeStudy to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]Paclitaxel, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Patients With Metastatic Breast CancerEnzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerComparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyMRI and Mammography Before Surgery in Patients With Stage I-II Breast CancerExemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticDocetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerGemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SA Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker MatchesA Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IGemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerChemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryConnect® MDS/AML Disease Registry
P6153
Q58407403-7E71A540-9AB2-41F3-BD59-8AA9E07A95EEQ58407779-3B491832-2022-4F8F-92E1-0CCBFA0F582BQ58845885-045625E1-4AE9-4BD2-91B8-990B3559587AQ58848851-CFFC5E4C-FFDE-4E01-A783-9F5B7D63F1CDQ61713087-7E43417F-4E0A-4664-9C63-3F526FF48EB7Q61713089-E234974F-3BA7-4B69-A01D-A9A01FFC899BQ61917783-B05E879A-A6BF-4C54-A9F8-5858013DEC84Q61921666-BED6448E-9923-4053-A9A6-0783A608736CQ61936011-8C5B206C-8E09-40B5-8394-AC2D5ED33159Q61938122-AC543F70-C1F0-4626-8FC1-53FF6755ECAEQ61981563-23542E4A-DC38-49F1-AC19-698278D85039Q62109997-89CF2570-E325-4A3E-BBC0-C9E1505EB555Q62110352-0DFBB382-16C7-4434-A3BA-4F438E160CCDQ62110934-8D5A9EE7-8EAD-4686-8DED-028ED669EE37Q62110947-2978A37F-F6E6-4B5E-9FCC-2C80976CAA0EQ63316114-AE5717E6-EA19-413E-9469-EA80CAB00A0EQ63317999-FF5F0404-ABD1-4DC0-A0C0-72357579275FQ63318717-CEF162CE-171D-4D56-B643-53761E6A83D9Q63320732-2877D666-2EE4-45D3-8BB8-F7C7A259FD3BQ63335032-A5E8474E-B75B-436D-8F7C-79B325213C26Q63335425-6C242340-DA39-46F6-861F-EE81843D305BQ63335890-5594A9A4-A0E6-422E-8CCD-427267B0C2AEQ63340391-D6E7DCA5-6F15-41DA-8B03-1006581722A0Q63402028-2FBC46B0-E6E5-4CCB-A65F-7E2C2A83EF89Q63570976-23D3728C-6D13-40AA-B10D-AF8792D84EC1Q63571350-8B2B2059-FF0C-41AE-AABC-69C37108FBEDQ63573128-2323BCA9-6EDB-43A4-BCF3-BB5DE4E39722Q64123497-0320445B-8713-4D87-9AA6-E99A0E627B78Q64123525-057BF9AD-E7D8-484F-B063-EB379BB5BA33Q64123549-42E33863-B1E9-43E0-A09B-52B3AFC51F91Q64150411-20CCDBB8-DF07-4FEA-AC0C-001A29A24C11Q64150460-7AFC2E91-E260-4563-868B-4357EA95C1D6Q64150548-5C7FCA26-9CF4-4F34-A340-ABC2897A86F9Q64151116-DE14F0CB-E5ED-4FF1-B541-FE3C03146487Q64151321-F6822EDC-A768-4B0A-AE14-0FA947830240Q64151443-9D85E26B-8DAE-4C16-8D2F-BF8AC221CFA1Q64170822-B8E93827-00CC-492D-A4F7-ABCDEE463971Q64171079-93B35FCB-2E3A-45AE-94A2-D68BCADB8309Q64171095-981BE6E7-E5B2-44DE-880B-CC3BCD4D9616
P6153
description
Krankenhaus
@de
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
hospital in Illinois, United States
@en
hôpital
@fr
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
ziekenhuis in Harvey, Verenigde Staten van Amerika
@nl
בית חולים בארצות הברית
@he
name
Ingalls Memorial Hospital
@en
type
label
Ingalls Memorial Hospital
@en
prefLabel
Ingalls Memorial Hospital
@en
P6366
P131
P213
0000 0004 0409 0904
P2427
grid.414617.1
P625
Point (-87.6596 41.6073)
P6366
1328302364